Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
ALZN holding history
Alzamend Neuro, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALZN overviewAll 13F holders of ALZNFull Q4 2025 holdings
- Shares (Q4 2025)
- 21,620
- Value
- $39.3K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 21,620 | $39.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 21,620 | $51.5K | <0.1% | +21,620 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −7,855−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q2 2024 | 78,545 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 78,545 | $78.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 78,545 | $69.9K | <0.1% | −57,139−42.1% | ReducedConverted for a 1-for-15 split | Holders |
| Q3 2023 | 2,035,253 | $482.4K | <0.1% | −1,999−0.1% | Reduced | Holders |
| Q2 2023 | 2,037,252 | $1.04M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,037,252 | $865.8K | <0.1% | −555,620−21.4% | Reduced | Holders |
| Q4 2022 | 2,592,872 | $1.46M | <0.1% | −1,502,903−36.7% | Reduced | Holders |
| Q3 2022 | 4,095,775 | $4.87M | <0.1% | +4,035,028+6,642.3% | Added | Holders |
| Q2 2022 | 60,747 | $53.0K | <0.1% | +60,747 | New | Holders |